Fate Therapeutics (FATE) Stock: Buy, Sell, or Hold?
FATE - Fate Therapeutics, Inc.
$2.08
0.01 (0.24%)
▲
5d:
+7.79%
30d:
-14.61%
90d:
-13.9%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 12, 2026
20d
Get Alerted When FATE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FATE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: FATE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: FATE is currently trading at $2.08, which is considered slightly low relative to its 30-day fair value range of $2.04 to $2.47.
Technical Outlook: Technically, FATE is in a downtrend. Immediate support is located at $1.75, while resistance sits at $2.27.
Market Sentiment: FATE scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.74 (+177.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FATE is in a downtrend. Immediate support is located at $1.75, while resistance sits at $2.27.
Market Sentiment: FATE scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.74 (+177.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.04 -
$2.47
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 177.5% below Wall St target ($5.74)
- BULLISH: Bottoming setup score 77/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$2.04 -
$2.47
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.28
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.14
Wall Street Target
$5.74
(+177.5%)
Revenue Growth (YoY)
9.2%
Share & Embed Analysis
Last updated: October 22, 2026 12:06 PM ET
Data refreshes hourly during market hours. Next update: 1:06 PM
Data refreshes hourly during market hours. Next update: 1:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FATE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 67 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 77 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 71 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 49 HOLD |
